首页  | 新闻播报

每日新闻播报(December 1)

chinadaily.com.cn 2020-12-01 16:44

Space workers monitor the status of Chang'e 5 at a control center in Beijing on Tuesday. [Photo/Xinhua]

>Probe prepares to land on moon
China's Chang'e-5 probe is preparing for a soft landing on the moon to undertake the country's first collection of samples from an extraterrestrial body.
The lander-ascender combination of the spacecraft separated from its orbiter-returner combination at 4:40 am Monday, according to the China National Space Administration (CNSA).
The spacecraft is performing well and communication with ground control is normal, CNSA said.
The lander-ascender combination will execute a soft landing on the moon and engage in automatic sampling. The orbiter-returner will continue orbiting about 200 km above the lunar surface and wait for rendezvous and docking with the ascender.
Launched on Nov 24, Chang'e-5 is one of the most complicated and challenging missions in China's aerospace history, as well as the world's first moon-sample mission in more than 40 years.

Candidates walk out of the No 3 Middle School in Nanchang, East China's Jiangxi province, after taking the national civil servant exam on Dec 2, 2018. [Photo/IC]

>More jobs on offer
Nearly 1.58 million people were expected to have sat for China's annual national civil service exam on Sunday, competing for 25,700 government jobs that include a large number of positions targeting new college graduates and those intending to work at grassroots institutions, putting the average chance of landing a government job next year at about one in 61.
In recent years, the hotly contested exam has offered more job opportunities for new college graduates and sought to encourage more job seekers to take grassroots positions.
The administration said nearly 60% of new government jobs for 2021 are reserved for fresh graduates, with most positions at the city or lower levels open exclusively to applicants who will graduate next year.
Over 8,300 jobs are located in western provinces or remote and less-developed regions. Prospective applicants for those positions do not have to meet as many requirements related to their areas of study and work experience.

Adult male panda Da Mao, one of two being returned to China by Canada's Calgary Zoo due to the difficulty of obtaining their food of fresh bamboo due to the coronavirus disease (COVID-19) related logistical problems, is seen in an undated photograph provided May 13, 2020. [Photo/Agencies]

>Pandas return home
Two giant pandas on Sunday landed in their homeland in Southwest China after prematurely finishing their stay at a Canadian zoo, as the COVID-19 pandemic disrupted their bamboo supply. "Da Mao" and "Er Shun," whose chartered flight arrived in Chengdu, capital of Sichuan province, early Sunday morning, have been sent to Chongqing Municipality for quarantine, according to the Chengdu Research Base of Giant Panda Breeding.
Canada's Calgary Zoo, from which the pair were returned, said earlier this year that COVID-19 travel restrictions made it difficult to transport bamboo to feed the pandas.
After negotiations, the two sides agreed to bring back the black-and-white stars to China ahead of schedule.
The two pandas arrived in Canada in 2013 as part of a 10-year agreement between Canada and China over the animal's protection and research.
After spending five years at the Toronto Zoo, the duo moved to the Calgary Zoo in March 2018 with twin cubs, "Jia Panpan" and "Jia Yueyue," who traveled home to China in January.


>COVID vaccine distribution
The UK is poised to become the first western country to approve a COVID-19 vaccine, with its independent regulator set to grant approval within days.
Deliveries of the vaccine developed by BioNTech and Pfizer would begin within hours of the authorization, according to government officials. The first injections could take place starting Dec 7.
Vaccines would normally be authorized by the European Medicines Agency until the end of the Brexit transition on Dec 31. However, the UK's Medicines and Healthcare Products Regulatory Agency has the power to temporarily authorize products, in cases of urgent public need.
An emergency US approval could come as soon as Dec 8-10, with shipments across the country starting within 24 hours of the announcement, according to US media reports.
The Advisory Committee on Immunization Practices, established by the US Centers for Disease Control and Prevention, will meet on Tuesday to vote on how a coronavirus vaccine will be given out when one is approved.

Find more audio news on the China Daily app.